Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-05

Clinical Trial Update: Ferritin and Iron Burden in SAH sIRB [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 clinical trial sponsored by Duke University evaluating ferritin and iron burden in subarachnoid hemorrhage, with dementia included among condi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: SAH, Dementia | Phase 1, Phase 2 | Status: RECRUITING